Cita APA

Bayes-Genis, A., Lupon, J., Revuelta-Lopez, E., Llibre, C., Gastelurrutia, P., Domingo, M., . . . Nunez, J. (2023). Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trial.

Citación estilo Chicago

Bayes-Genis, Antoni, et al. Evolocumab Has No Effects On Heart Failure With Reduced Ejection Fraction Injury Biomarkers: The EVO-HF Trial. 2023.

Cita MLA

Bayes-Genis, Antoni, et al. Evolocumab Has No Effects On Heart Failure With Reduced Ejection Fraction Injury Biomarkers: The EVO-HF Trial. 2023.